Irene Campi

Efficacy of B-Cell Targeted Therapy With Rituximab in Patients With Active Moderate to Severe Graves' Orbitopathy: A Randomized Controlled Study

Mario Salvi, Guia Vannucchi, Nicola Currò et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 390 citations · Full text

Mutations in the selenocysteine insertion sequence–binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans

Erik Schoenmakers, Maura Agostini, Catherine Mitchell et al. · Journal of Clinical Investigation · 2010 · 308 citations · Full text

Spermatogenesis, Genetics, Lipid Peroxidation +18

Treatment of Graves’ disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study

Mario Salvi, Guia Vannucchi, Irene Campi et al. · European Journal of Endocrinology · 2007 · 262 citations

Loss-of-function mutations in IGSF1 cause an X-linked syndrome of central hypothyroidism and testicular enlargement

Yu Sun, Beata Bąk, Nadia Schoenmakers et al. · Nature Genetics · 2012 · 215 citations · Full text

Developmental Biology, Mendelian Disorder, Central Hypothyroidism +9

Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial

George J. Kahaly, Michaela Riedl, J. König et al. · The Lancet Diabetes & Endocrinology · 2018 · 212 citations

Methylprednisolone Versus Methylprednisolone, Endocrine Disease, Medicine +5